Patents by Inventor Bjorn Steen Skalhegg

Bjorn Steen Skalhegg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230263155
    Abstract: The invention relates to the use of compounds of formula (I), stereoisomers, and physiologically tolerable salts thereof, to enhance the motility of sperm obtained from a non-human mammal: wherein in formula I: X is —NR?— (in which R? is H or C1-3 alkyl, e,g, —CH3), —O—, —S— or —CH2—; Y is —S—, —O—, —NR?— (in which R? is H or C1-3 alkyl, e.g.
    Type: Application
    Filed: April 30, 2021
    Publication date: August 24, 2023
    Inventors: Ken Roger ROSENDAL, Tuva Holt HERENG, Steffi LUNDVALL, Espen Marcelius GJEMS, Håvard Hildeng HAUGE, Bjørn Steen SKÅLHEGG
  • Patent number: 7491534
    Abstract: The invention provides methods for altering the expression profile of a cell to convert the cell from one cell type to a desired cell type (e.g., T-cells). These reprogrammed cells may be used in a variety of medical applications for treating a mammal in need of a particular cell type.
    Type: Grant
    Filed: April 30, 2003
    Date of Patent: February 17, 2009
    Assignee: Kirin Holdings Kabushiki Kaisha
    Inventors: Philippe Collas, James M. Robl, Bjorn Steen Skalhegg
  • Publication number: 20040072288
    Abstract: The invention provides methods for altering the expression profile of a cell to convert the cell from one cell type to a desired cell type (e.g., T-cells). These reprogrammed cells may be used in a variety of medical applications for treating a mammal in need of a particular cell type.
    Type: Application
    Filed: April 30, 2003
    Publication date: April 15, 2004
    Inventors: Philippe Collas, James M. Robl, Bjorn Steen Skalhegg